IOL Material Market Seen Reaching $5.92 Billion by 2030

The intraocular lens material market is projected to grow from $4.31 billion in 2025 to $5.92 billion by 2030, driven by cataract surgeries, diabetes-related eye disease and demand for premium vision-correction lenses. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The intraocular lens material market sits at the center of cataract and refractive surgery, where demand is rising as more patients seek vision correction. - Growth in the category reflects broader pressure from aging populations, diabetes-related eye disease and expanding access to eye care. - The market’s direction matters for lens makers because product mix is shifting toward premium, customized and biocompatible materials.

What happened: - The intraocular lens (IOL) material market is forecast to grow from $4.31 billion in 2025 to $4.6 billion in 2026, a 6.6% CAGR. - The market is projected to reach $5.92 billion by 2030, at a 6.5% CAGR. - The Business Research Company published the outlook on Aug. 13, 2026. - A free sample of the report and the full market report are available online.

The details: - IOL materials are biocompatible substances used to replace the eye’s natural lens during cataract or refractive surgery. - The materials must stay optically clear, resist degradation inside the eye and limit interaction with surrounding tissue. - Depending on the procedure, IOL materials are engineered to be flexible or rigid to support precise light transmission and sharp retinal focus. - The report ties near-term growth to more cataract surgeries, higher demand for vision-correction procedures, improved ophthalmic surgery techniques, better access to eye care and wider awareness of IOL options. - The longer-term forecast points to an aging population with vision impairment, increased use of premium IOLs, more refractive surgeries, better manufacturing technology and more customized vision-correction solutions. - Emerging trends include advanced acrylic and collamer materials, stronger demand for multifocal and toric lenses, long-term optical stability, tailored IOL designs, and better biocompatibility and flexibility. - Diabetes-related eye disorders are a major growth driver, including diabetic retinopathy, cataracts and glaucoma linked to persistent high blood sugar. - The report says IOL materials help restore clear vision after cataract surgery, correct refractive errors and improve outcomes for patients with diabetic retinopathy. - The European Medical Journal reported in July 2023 that about 9.6 million people in the U.S. had diabetic retinopathy. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth through the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables.

Between the lines: - Demand is moving beyond basic lens replacement toward more specialized products that can support individualized correction and better long-term performance. - Diabetes is likely to remain a steady demand source because it expands the pool of patients at risk for cataracts and other vision-threatening conditions. - The regional split suggests mature demand in North America and faster expansion in markets where eye-care access and surgery volumes are still rising.

What's next: - Manufacturers are likely to keep investing in material innovation, especially around acrylic, collamer, multifocal and toric lenses. - Market growth will likely depend on how quickly providers adopt customized IOL designs and newer surgical technologies. - Regional expansion in Asia-Pacific will be a key indicator to watch as the forecast period advances.

The bottom line: - The IOL material market is on track for steady, mid-single-digit growth through 2030, with diabetes, aging populations and premium lens adoption driving the next phase.